Displaying posts published in

December 2016

Russian Hackers and American Hacks The CIA that misjudged Putin for years is now sure of his motives.

Somewhere in the Kremlin Vladimir Putin must be laughing. The Russian strongman almost certainly sought to undermine public confidence in American democracy this year, and as the Obama Administration leaves town it is playing into his hands.

That’s the real story behind the weekend reports that U.S. intelligence services have concluded that Russia intervened to assist Donald Trump’s presidential campaign. The stories are attributed to “senior administration” officials who won’t go on the record but assert murky details that are impossible to verify without seeing the evidence.

Mr. Trump is denouncing the claims with his usual subtlety, but he has a point about their timing and nature. “I don’t want anyone hacking us,” Mr. Trump said on Fox News Sunday, while blaming the leaks on Democrats. “I think it’s ridiculous” and “I don’t believe it.”

Democrats are still in shock from their defeat, and many want to add the Kremlin to FBI Director James Comey, fake news and the Electoral College as excuses that cast doubt on the legitimacy of Mr. Trump’s victory.

Israel’s economy defies BDS Ambassador (Ret.) Yoram Ettinger

1. In December, 2016, Israel is unprecedentedly integrated into the global economy, highlighting the successful battle against BDS (boycott, divestment and sanctions), while rejecting pessimism and fatalism.

2. According to a Bloomberg study: “An examination of foreign capital flow into Israel shows a near tripling from 2005 when the so-called BDS was started…. Israel’s economy is expected to grow 2.8% in 2016, compared with 1.8% for the US and the EU. In 2015, Israel’s industrial high-tech exports rose 13%, from 2014, to $23.7BN….”

3. 2016 is already a record year for total (mostly foreign) investments in Israel’s young high tech companies, exceeding the $4.4BN invested in 2015. For instance, Israel’s NeuroDerm, which develops drugs for central nervous system diseases, is expected to raise $75MN, on NASDAQ, by December 12, 2016. Some of the recent investments were made by the US-based Johnson & Johnson’s Development Corporation, the Australian Stock Exchange, the German medical equipment giant B. Braun Melsungen AG, China’s Internet giant Alibaba and Japan’s Sun Corporation.

4. A trilateral cooperation agreement has been concluded between Israel’s Mobileye – a collision avoidance sensor developer – Delphi Automotive, the UK-based global automotive parts manufacturer and the Silicon Valley-based Intel, aiming to manufacture a self-driving car by 2019. A similar partnership was struck between Mobileye, Intel and the German car giant, BMW.

5. A wave of acquisitions of Israeli companies by global giants persists, as evidenced by the November, 2016 acquisition of Israel’s valve repair device company, Valtech Cardio Ltd., by the Irvine, California-based Edwards Lifesciences Corp., for $340MN in stock and cash, in addition to $350MN in milestone payments over ten years and $300MN for Valtech’s research and development program. Just like 200-250 other (mostly US) major global hightech companies, Edwards has leveraged Israel’s brain-power by operating a research and development center in Israel, since the 2004 acquisition of Israel’s PVT for $90MN and milestone payments.

6. The London-based mega-billion-dollar Chinese/European XIO Group has acquired Israel’s Meitav-Dash Investment House for $400MN. In 2015, XIO acquired Israel’s medical device company, Lumenis, for $510MN. China’s telecommunications giant, Xinwei, is negotiating the acquisition of Israel’s Spacecom Satellite Communications for $190MN, reflecting the surging Chinese interest in the Israeli market and the significantly expanding Israel-China trade balance from $50MN in 1990 to $11BN in 2015, in addition to $15BN in acquisition of Israeli companies. The Hong Kong-based Rightleder Holding Group aims to acquire Israel’s sewage recycling (water purification) company, Advanced Membrane Separation. Also two Chinese capital funds, CDH and ZZ explore the acquisition of ironSource, Israel’s largest Internet company, for $1BN.

7. The Israel-India trade balance surged from $200MN in 1992 – when diplomatic relations were normalized – to $3BN in 2009 and $5BN in 2015, accompanied by a rise in two-way-tourism, paving the road to a negotiated free-trade-agreement, and highlighting India as one of Israel’s fastest growing trade partners in the commercial and defense areas. New Delhi has become the top customer for Israel’s defense industries, in addition to a series of co-development and co-production initiatives with Israel – in the face of joint economic and national security challenges – while Israel has become the number two/three exporter of military systems to India, following Russia and the USA.

8. On November 16, 2016, India signed $1.4BN contracts with the Israel Aerospace Industries (IAI), purchasing two additional Phalcon/IL-76 Airborne Early Warning and Control Systems and ten Heron unmanned aerial vehicles. IAI has submitted a proposal for the co-development, in India, of an advanced version of the Heron. The growing Israel-India defense ties are demonstrated by the recent Indian procurement of Rafael’s Gil anti-tank missiles, upgrades of Indian tanks by Elbit Systems and a joint development of the Barak-8 surface-to-air missile.

GOOD NEWS FROM AMAZING ISRAEL: MICHAEL ORDMAN

ISRAEL’S MEDICAL ACHIEVEMENTS

Key enzyme discovery in fight against cancer. Israel Technion researchers have found that the ubiquitin enzyme RNF4 binds to oncogenic proteins to give cancer cells longer lives. Increased levels of RNF4 have been found in colon and breast cancer patients. Removing or inhibiting RNF4 leads to the death of cancer cells.
http://www.technion.ac.il/en/2016/12/crucial-enzyme-for-tumor-development/
https://www.youtube.com/watch?v=yC53-lREHQg

Success in Sickle-Cell Disease trial. Israeli biotech Gamida Cell published positive results in its Phase I/II trial of NiCord, for the treatment of Sickle-Cell Disease (SCD). All the patients that completed the trial were free of SCD symptoms.
http://www.globes.co.il/en/article-gamida-reports-positive-nicord-results-1001165382

Full remission in Leukemia treatment trial. Israel’s BioSight has reported that in treating patients with its Astarabine leukemia treatment, three patients with late-stage leukemia achieved full remission to date. Good results were also reported for older patients over 80.
http://www.globes.co.il/en/article-biosight-completes-successful-cancer-drug-trial-1001165482

Sleep disorder treatment for autistic kids. Israeli biotech Neurim (featured Nov 20) has signed marketing agreements for its new Rx PedPRM treatment for sleep disorders in children with autism spectrum disorders and neurogenetic diseases. Kuhnil will market Rx PedPRM in Korea; Aspen in Australia and New Zealand.
http://www.neurim.com/news/2016-12-06/neurim-pharmaceuticals-paediatric-prolonged-release-melatonin-pedprm-to-be-marketed-by-kuhnil-pharmaceutical-in-south-korea/

Portable blood test for malaria. (TY Atid-EDI) Israel’s Sight Diagnostics (SightDx) (see here) in collaboration with the US Army Medical Research Directorate Kenya (USAMRD-K) is developing a portable malaria and complete blood count (CBC) reader. It will be calibrated and tested in clinical trials at the USAMRD-K Field Station in Kisumu, Kenya. http://www.prnewswire.com/news-releases/sight-diagnostics-ltd-and-the-united-states-army-announce-a-joint-collaboration-598337901.html

14 more hearts mended in Tanzania. Israeli surgeons from Save a Child’s Heart were back (again) in Tanzania, fixing another fourteen young, faulty hearts. The Israelis worked with a German team from Berlin’s Deutsches Herzzentrum during the five-day medical mission.
http://www.israel21c.org/israeli-german-medical-team-gives-14-children-gift-of-life/

Device to keep track of insulin doses. Israel’s Insulog is a device to help diabetes patients keep track of their insulin doses and prevent accidental overdoses. It snaps onto most types of disposable insulin pen, monitors and logs the dose and sends data to a smartphone app. It displays details of the last dose to the user.
Insulog is funding on Indiegogo. https://www.youtube.com/watch?v=0vscMWDcjlA
http://www.timesofisrael.com/israel-smart-tracker-aims-to-keep-tabs-on-insulin-shots/
https://www.indiegogo.com/projects/insulog-the-smart-snap-on-insulin-tracker-health–2#/